{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:27:19Z","timestamp":1793330839709,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s13555-016-0160-3","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T09:32:52Z","timestamp":1480930372000},"page":"37-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management"],"prefix":"10.1007","volume":"7","author":[{"given":"Gloria","family":"Gonz\u00e1lez-Saldivar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Rodr\u00edguez-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Gerardo","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"G\u00f3mez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,5]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7954-8-29","volume":"8","author":"J Boyle","year":"2010","unstructured":"Boyle J, Thompson T, Gregg E, Barker L, Williamson D. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:1.","journal-title":"Popul Health Metr"},{"key":"160_CR2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM199109263251307","volume":"325","author":"DE Moller","year":"1991","unstructured":"Moller DE, Flier JS. Insulin resistance\u2014mechanisms, syndromes, and implications. N Engl J Med. 1991;325:938\u201348.","journal-title":"N Engl J Med"},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"U Jung","year":"2014","unstructured":"Jung U, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184\u2013223.","journal-title":"Int J Mol Sci"},{"key":"160_CR4","doi-asserted-by":"publisher","unstructured":"Napolitano M, Megna M, Monfrecola G. Insulin resistance and skin diseases. Sci World J. 2015. doi: 10.1159\/000245731 .","DOI":"10.1159\/000245731"},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1442-200X.2003.01812.x","volume":"45","author":"H Yamazaki","year":"2003","unstructured":"Yamazaki H, Ito S, Yoshida H. Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children. Pediatr Int. 2003;45:701\u20135.","journal-title":"Pediatr Int"},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1054-139X(00)00217-2","volume":"28","author":"Q Mukhtar","year":"2001","unstructured":"Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health. 2001;28:372\u20136.","journal-title":"J Adolesc Health"},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI27073","volume":"116","author":"DS Edgerton","year":"2006","unstructured":"Edgerton DS, et al. Insulin\u2019 s direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest. 2006;116:521\u20137.","journal-title":"J Clin Invest"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/dc08-s264","volume":"31","author":"MH Shanik","year":"2008","unstructured":"Shanik MH, et al. Insulin resistance and hyperinsulinemia: Is hyperinsulinemia the cart or the horse? Diabet Care. 2008;31:262\u20138.","journal-title":"Diabet Care"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","volume":"5","author":"T Hermanns-L\u00ea","year":"2004","unstructured":"Hermanns-L\u00ea T, Scheen A, Pi\u00e9rard GE. Acanthosis nigricans associated with insulin resistance. Am J Clon Dermatol. 2004;5:199\u2013203.","journal-title":"Am J Clon Dermatol"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2006.12.004","volume":"56","author":"G Yosipovitch","year":"2007","unstructured":"Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56:901\u201316.","journal-title":"J Am Acad Dermatol"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0365-05962012000100012","volume":"87","author":"M Barbato","year":"2012","unstructured":"Barbato M, et al. Association of acanthosis nigricans and skin tags with insulin resistance. An Bras Dermatol. 2012;87:97\u2013104.","journal-title":"An Bras Dermatol"},{"key":"160_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1095-6433(03)00011-4","volume":"136","author":"L Cordain","year":"2003","unstructured":"Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 2003;136:95\u2013112.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ecl.2013.07.004","volume":"42","author":"B Murphy-Chutorian","year":"2013","unstructured":"Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus. a review. Endocrinol Metab Clin N Am. 2013;42:869\u201398.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0019-5154.84765","volume":"56","author":"OS Safoury El","year":"2011","unstructured":"El Safoury OS, Ibrahim M. A clinical evaluation of skin tags in relation to obesity, type 2 diabetis mellitus, age, and sex. Indian J Dermatol. 2011;56:393\u20137.","journal-title":"Indian J Dermatol"},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10238-009-0086-5","volume":"10","author":"R Sari","year":"2010","unstructured":"Sari R, Akman A, Alpsoy E, Balci MK. The metabolic profile in patients with skin tags. Clin Exp Med. 2010;10:193\u20137.","journal-title":"Clin Exp Med"},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-4632.2007.03287.x","volume":"46","author":"A Rasi","year":"2007","unstructured":"Rasi A, Soltani-Arabshahi R, Shahbazi N. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case\u2013control study. Int J Dermatol. 2007;46:1155\u20139.","journal-title":"Int J Dermatol"},{"key":"160_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s005920200014","volume":"39","author":"S Demir","year":"2002","unstructured":"Demir S, Demir Y. Acrochordon and impaired carbohydrate metabolism. Acta Diabetol. 2002;39:57\u20139.","journal-title":"Acta Diabetol"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/ijd.12463","volume":"53","author":"WH Schilling","year":"2014","unstructured":"Schilling WH, Crook MA. Cutaneous stigmata associated with insulin resistance and increased cardiovascular risk. Int J Dermatol. 2014;53:1062\u20139.","journal-title":"Int J Dermatol"},{"key":"160_CR19","first-page":"1184","volume":"294","author":"J Margolis","year":"1976","unstructured":"Margolis J, Margolis LS. Skin tags-a frequent sign of diabetes mellitus. N Engl J Med. 1976;294:1184.","journal-title":"N Engl J Med"},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2340\/0001555567175177","volume":"67","author":"M Kahana","year":"1987","unstructured":"Kahana M, et al. Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol. 1987;67:175\u20137.","journal-title":"Acta Derm Venereol"},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1468-3083.2012.04475.x","volume":"26","author":"B Behm","year":"2012","unstructured":"Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012;26:1203\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"160_CR22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7547\/87507315-80-9-496","volume":"80","author":"J Men","year":"1990","unstructured":"Men J, Boberg J. Fibroepithelial polyps. An unusual case report. J Am Podiatr Med Assoc. 1990;80:496\u20138.","journal-title":"J Am Podiatr Med Assoc"},{"key":"160_CR23","first-page":"1961","volume-title":"Dermatology","author":"H Kamino","year":"2012","unstructured":"Kamino H, Reddy VB, Pui J. Dermatology. Philadelphia: Elsevier; 2012. p. 1961."},{"key":"160_CR24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/B978-1-4160-9976-5.10271-8","volume-title":"Dermatopathology: high-yield pathology","author":"NK Brinster","year":"2011","unstructured":"Brinster NK, Liu V, Diwan AH, McKee PH. Dermatopathology: high-yield pathology. Edinburgh: Elsevier; 2011. p. 446."},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-323-05267-2.00012-1","volume-title":"Pfenninger and Fowler\u2019s Procedures for Primary Care","author":"JL Pfenninger","year":"2011","unstructured":"Pfenninger JL. Pfenninger and Fowler\u2019s Procedures for Primary Care. Philadelphia: Elsevier; 2011. p. 69\u201384."},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2006.08.016","volume":"57","author":"S Sinha","year":"2007","unstructured":"Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007;57:502\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"160_CR27","first-page":"100","volume":"9","author":"D Dobrev","year":"1958","unstructured":"Dobrev D. Case of acanthosis nigricans associated with gastric cancer. Suvr Med. 1958;9:100\u20133.","journal-title":"Suvr Med"},{"key":"160_CR28","first-page":"493","volume":"40","author":"G Lindewall","year":"1960","unstructured":"Lindewall G. Acanthosis nigricans associated with carcinoma of the stomach: a case report. Acta Derm Venereol. 1960;40:493\u20139.","journal-title":"Acta Derm Venereol"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jama.1909.92550170001001g","volume":"53","author":"S Pollitzer","year":"1909","unstructured":"Pollitzer S. Acanthosis nigricans: a symptom of a disorder of the abdominal sympathetic. JAMA. 1909;53:1369\u201373.","journal-title":"JAMA"},{"key":"160_CR30","unstructured":"Janovsky V. Acanthosis nigricans. In: Unna PG, Morris M, Besnier E, editors. International atlas of rare skin diseases. London: HK Lewis & Co; 1891. p. 4\u20135."},{"key":"160_CR31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diacare.22.10.1655","volume":"22","author":"JP Burke","year":"1999","unstructured":"Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabet Care. 1999;22:1655\u20139.","journal-title":"Diabet Care"},{"key":"160_CR32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0034-1387732","volume":"123","author":"M G\u00f3mez-Flores","year":"2014","unstructured":"G\u00f3mez-Flores M, et al. Implications of a clinically ignored site of acanthosis nigricans: the knuckles. Exp Clin Endocrinol Diabet. 2014;123:27\u201333.","journal-title":"Exp Clin Endocrinol Diabet"},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1590\/S0365-05962012000400002","volume":"87","author":"C Kluczynik","year":"2012","unstructured":"Kluczynik C, et al. Acanthosis nigricans and insulin resistance in overweight children and adolescents. An Bras Dermatol. 2012;87:531\u20137.","journal-title":"An Bras Dermatol"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(89)80149-4","volume":"87","author":"CA Stuart","year":"1989","unstructured":"Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87:269\u201372.","journal-title":"Am J Med"},{"key":"160_CR35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.0926-9959.2001.00239.x","volume":"15","author":"MA Mu\u00f1oz-P\u00e9rez","year":"2001","unstructured":"Mu\u00f1oz-P\u00e9rez MA, Camacho F. Acanthosis nigricans: a new cutaneous sign in severe atopic dermatitis and Down syndrome. J Eur Acad Dermatol Venereol. 2001;15:325\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"160_CR36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1370\/afm.678","volume":"5","author":"AS Kong","year":"2007","unstructured":"Kong AS, et al. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in Southwestern US primary care practices. Ann Fam Med. 2007;5:202\u20138.","journal-title":"Ann Fam Med"},{"key":"160_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0738-081X(93)90076-O","volume":"11","author":"LY Matsuoka","year":"1993","unstructured":"Matsuoka LY, Wortsman J, Goldman J. Acanthosis Nigricans. Clin Dermatol. 1993;11:21\u20135.","journal-title":"Clin Dermatol"},{"key":"160_CR38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4103\/0019-5154.91828","volume":"56","author":"N Puri","year":"2011","unstructured":"Puri N. A study of pathogenesis of acanthosis nigricans and its clinical implications. Indian J Dermatol. 2011;56:678\u201383.","journal-title":"Indian J Dermatol"},{"key":"160_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/2229-5178.137765","volume":"5","author":"MM Phiske","year":"2014","unstructured":"Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014;5:239\u201349.","journal-title":"Indian Dermatol Online J"},{"key":"160_CR40","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.1991.01680070039003","volume":"127","author":"GL Darmstadt","year":"1991","unstructured":"Darmstadt GL, Yokel BK, Horn TD. Treatment of acanthosis nigricans with tretinoin. Arch Dermatol. 1991;127:1139\u201340.","journal-title":"Arch Dermatol"},{"key":"160_CR41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D37MF6G290","volume":"14","author":"SP Higgins","year":"2008","unstructured":"Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J. 2008;14:2.","journal-title":"Dermatol Online J"},{"key":"160_CR42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1468-3083.2008.02931.x","volume":"23","author":"C Adigun","year":"2009","unstructured":"Adigun C, Pandya A. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream. J Eur Dermatol Venereol. 2009;23:486\u20137.","journal-title":"J Eur Dermatol Venereol"},{"key":"160_CR43","first-page":"33","volume":"71","author":"SH Blobstein","year":"2003","unstructured":"Blobstein SH. Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity. Cutis. 2003;71:33\u20134.","journal-title":"Cutis"},{"key":"160_CR44","first-page":"1093","volume-title":"Dermatology","author":"LC Sperling","year":"2012","unstructured":"Sperling LC, SInclair R, Shabrawi-Caelen L. Dermatology. Philadelphia: Elsevier; 2012. p. 1093\u20138."},{"key":"160_CR45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2008.03508.x","volume":"71","author":"JG Gonzalez-Gonzalez","year":"2009","unstructured":"Gonzalez-Gonzalez JG, Mancillas-Adame LG, Fernandez-Reyes M, Lavalle-Gonzalez FJ, Ocampo-Candiani J. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol. 2009;71:494\u20139.","journal-title":"Clin Endocrinol"},{"key":"160_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","volume":"164","author":"U Blume-Peytavi","year":"2011","unstructured":"Blume-Peytavi U, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol. 2011;164:5\u201315.","journal-title":"Br J Dermatol"},{"key":"160_CR47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","volume":"52","author":"EA Olsen","year":"2005","unstructured":"Olsen EA, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52:301\u201311.","journal-title":"J Am Acad Dermatol"},{"key":"160_CR48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","volume":"149","author":"G Severi","year":"2003","unstructured":"Severi G, et al. Androgenetic alopecia in men aged 40\u201369\u00a0years: prevalence and risk factors. Br J Dermatol. 2003;149:1207\u201313.","journal-title":"Br J Dermatol"},{"key":"160_CR49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2230.2008.03118.x","volume":"34","author":"L Nabaie","year":"2009","unstructured":"Nabaie L, et al. Androgenic alopecia and insulin resistance: are they really related? Clin Exp Dermatol. 2009;34:694\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"160_CR50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(00)02763-X","volume":"356","author":"V Matilainen","year":"2000","unstructured":"Matilainen V, Koskela P, Kein\u00e4nen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet. 2000;356:1165\u20136.","journal-title":"Lancet"},{"key":"160_CR51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4103\/0378-6323.116730","volume":"79","author":"F Kaliyadan","year":"2013","unstructured":"Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79:613\u201325.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"160_CR52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ecl.2007.03.004","volume":"36","author":"N Otberg","year":"2007","unstructured":"Otberg N, Finner AM, Shapiro J. Androgenetic Alopecia. Endocrinol Metab Clin N Am. 2007;36:379\u201398.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"160_CR53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/120347549800300103","volume":"3","author":"M Sawaya","year":"1998","unstructured":"Sawaya M, Shalita A. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg. 1998;3:9\u201315.","journal-title":"J Cutan Med Surg"},{"key":"160_CR54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/2229-5178.137776","volume":"5","author":"O Bakry","year":"2014","unstructured":"Bakry O, Shoeib MA, El Shafiee M, Hassan A. Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study. Indian Dermatol Online J. 2014;5:276\u201391.","journal-title":"Indian Dermatol Online J"},{"key":"160_CR55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijcard.2014.07.079","volume":"176","author":"N Trieu","year":"2014","unstructured":"Trieu N, Eslick GD. Alopecia and its association with coronary heart disease and cardiovascular risk factors: a meta-analysis. Int J Cardiol. 2014;176:687\u201395.","journal-title":"Int J Cardiol"},{"key":"160_CR56","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.317.7162.865","volume":"317","author":"R SInclair","year":"1998","unstructured":"SInclair R. Male pattern androgenetic alopecia. BMJ. 1998;317:865\u20139.","journal-title":"BMJ"},{"key":"160_CR57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamadermatol.2013.130","volume":"149","author":"L-H Su","year":"2013","unstructured":"Su L-H, Chen L-S, Lin S-C, Chen H-H. Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease. JAMA Dermatol. 2013;149:601\u20136.","journal-title":"JAMA Dermatol"},{"key":"160_CR58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0001-7310(09)73176-X","volume":"100","author":"A Tosti","year":"2009","unstructured":"Tosti A, Torres F. Dermoscopy in the diagnosis of hair and scalp disorders. Actas Dermosifiliogr. 2009;100:114\u20139.","journal-title":"Actas Dermosifiliogr"},{"key":"160_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1610-0379.2011.07802.x","volume":"9","author":"A Blumeyer","year":"2011","unstructured":"Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9:1\u201357.","journal-title":"J Dtsch Dermatol Ges"},{"key":"160_CR60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2133.1999.03030.x","volume":"141","author":"TF Cash","year":"1999","unstructured":"Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol. 1999;141:398\u2013405.","journal-title":"Br J Dermatol"},{"key":"160_CR61","first-page":"142","volume":"8","author":"R Dumitrescu","year":"2015","unstructured":"Dumitrescu R, Mehedintu C, Briceag I, Purcarea V, Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life. 2015;8:142\u20135.","journal-title":"J Med Life"},{"key":"160_CR62","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(00)02770-7","volume":"356","author":"W Jeffcoate","year":"2000","unstructured":"Jeffcoate W, Kong M-F. Diab\u00e8te des femmes \u00e0 barbe: a classic paper reread. Lancet. 2000;356:1183\u20135.","journal-title":"Lancet"},{"key":"160_CR63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/EJE-15-0275","volume":"1","author":"A Vryonidou","year":"2015","unstructured":"Vryonidou A, Paschou S, Muscogiuri G, Orio F, Goulis D. Metabolic Syndrome through the females life cycle. Eur J Endocrinol. 2015;1:153.","journal-title":"Eur J Endocrinol"},{"key":"160_CR64","first-page":"613","volume":"84","author":"L Poretsky","year":"1994","unstructured":"Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obs Gynecol. 1994;84:613\u201321.","journal-title":"Obs Gynecol"},{"key":"160_CR65","doi-asserted-by":"crossref","first-page":"847-e1","DOI":"10.1016\/j.jaad.2014.05.007","volume":"71","author":"E Housman","year":"2014","unstructured":"Housman E, Reynolds RV. Polycystic ovary syndrome: a review for dermatologists Part I. Diagnosis and manifestations. J Am Acad Dermatol. 2014;71:847-e1.","journal-title":"J Am Acad Dermatol"},{"key":"160_CR66","first-page":"3078","volume":"83","author":"E Knochenhauer","year":"1998","unstructured":"Knochenhauer E, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"160_CR67","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey J. Clinical assessment of body hair in women. J Clin Endocrinol Metab. 1961;21:1440\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"160_CR68","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","volume":"24","author":"RL Rosenfield","year":"2005","unstructured":"Rosenfield RL. Hirsutism. NEJM. 2005;24:2578\u201388.","journal-title":"NEJM"},{"key":"160_CR69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1701-2163(16)30274-2","volume":"24","author":"P Claman","year":"2002","unstructured":"Claman P. SOGC clinical practice guidelines. Hirsutism: evaluation and treatment. J Obs Gynaecol Can. 2002;24:62\u201373.","journal-title":"J Obs Gynaecol Can"},{"key":"160_CR70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/0004-2730000002923","volume":"58","author":"A Hohl","year":"2014","unstructured":"Hohl A, Ronsoni MF, Oliveira M. Hirsutism: diagnosis and treatment. Arq Bras Endocrinol Metab. 2014;58:97\u2013107.","journal-title":"Arq Bras Endocrinol Metab"},{"key":"160_CR71","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, et al. Criteria for defining polycyctic ovary syndrome as a predominantly hyperandrogenetic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"160_CR72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2340\/00015555-1677","volume":"93","author":"BC Melnik","year":"2013","unstructured":"Melnik BC, John SM, Plewig G. Acne: risk indicator for increased body mass index and insulin resistance. Acta Derm Venereol. 2013;93:644\u20139.","journal-title":"Acta Derm Venereol"},{"key":"160_CR73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1684\/ejd.2014.2405","volume":"24","author":"B Demir","year":"2014","unstructured":"Demir B, et al. Changes in serum desnutrin levels in patients with acne vulgaris. Eur J Dermatol. 2014;24:589\u201393.","journal-title":"Eur J Dermatol"},{"key":"160_CR74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/exd.12885","volume":"25","author":"G Monfrecola","year":"2016","unstructured":"Monfrecola G, et al. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients\u2019 skin. Exp Dermatol. 2016;25:153\u20135.","journal-title":"Exp Dermatol"},{"key":"160_CR75","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685\u201397.","journal-title":"Lancet"},{"key":"160_CR76","doi-asserted-by":"crossref","first-page":"859-e1","DOI":"10.1016\/j.jaad.2014.05.009","volume":"71","author":"E Buzney","year":"2014","unstructured":"Buzney E, Sheu J, Buzney C, Reynolds R. Polycystic ovary syndrome: A review for dermatologists: Part II. Treatment. J Am Acad Dermatol. 2014;71:859-e1.","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-016-0160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:22:36Z","timestamp":1718929356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-016-0160-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,5]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s13555-016-0160-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,5]]}}}